|
|
Volumn 368, Issue 1, 2013, Pages 84-86
|
|
C-reactive protein, fibrinogen, and cardiovascular risk
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL MARKER;
C REACTIVE PROTEIN;
FIBRINOGEN;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
BLOOD PRESSURE MONITORING;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CHOLESTEROL BLOOD LEVEL;
FIBRINOGEN BLOOD LEVEL;
HAZARD RATIO;
HUMAN;
INFLAMMATION;
LETTER;
PRIORITY JOURNAL;
PROGNOSIS;
RISK ASSESSMENT;
FEMALE;
MALE;
METABOLISM;
NOTE;
BLOOD LEVEL;
CARDITIS;
DISEASE ASSOCIATION;
DRUG COST;
OUTCOME ASSESSMENT;
PATIENT ASSESSMENT;
PRACTICE GUIDELINE;
PREDICTION;
PREDICTIVE VALUE;
PROSPECTIVE STUDY;
SEX DIFFERENCE;
C-REACTIVE PROTEIN;
CARDIOVASCULAR DISEASES;
FEMALE;
FIBRINOGEN;
HUMANS;
MALE;
|
|
EID: 84871810297
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1213688 Document Type: Letter |
|
Times cited : (13)
|
|
References (1)
|
